Nascent Biotech – Changing the Biotechnology Industry

  • facebook
  • twitter
  • instagram
  • pinterest
  • google-news

Vero Beach, Florida, United States, 28th Aug 2022,  Nascent Biotech is an up-and-coming Biotech industry leader that has developed a proprietary product by the name of Pritumumab (PTB). Pritumumab is an antibody—that naturally occurs within humans—that has been isolated and derived by Nascent Biotech using a groundbreaking contemporary biotechnological framework. Pritumumab has large potential in the cancer industry and can be used in cancer treatment. 

The global brain tumor drug market accounted for ~$3.5 billion in 2022, with a projected growth rate of 7.2%. Biotechnology companies play a pivotal role in our everyday life and have all increased in importance and value following the global shift of COVID-19. Companies such as Nascent Biotech have the ability to eat up a large portion of the market share with their modern techniques and products in the cancer-fighting arena. 

In a statement from Nascent Biotech CEO Sean Carrick, he discusses the current position of Nascent Biotech, and its future potential: “The company is moving forward as expected with our phase I clinical trial. In the process, we are learning a lot about ​​Pritumumab. We believe that, as we progress forward with phase I clinical trails and move into phase II, achievement of our milestones will drive significant value to the company and the shareholders.” With the Pritumumab trials moving forward, now appears to be the perfect time to get a piece of the pie, before the company expands rapidly.

On top of this, the Biotech sector is one of the healthiest and strongest sectors in the modern market. It appears that the sector is going to be growing rapidly in the coming months and years. Investors should explore this area, as it appears to be a very good look to invest in early. Following the current market trends, this stock has the potential to reach $3 per share once the trials go into phase II of the clinical trials, and even more following that. 

ABOUT NASCENT BIOTECH

Nascent Biotech, Inc. (OTCQB:NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various cancers and viral infections, helping millions of people worldwide. Its products are not commercially available. For further information please visit our website www.nascentbiotech.com. Our lead candidate, Pritumumab (PTB), is a monoclonal antibody (Mab) that will be studied in Phase I clinical trials for the treatment of Brain Cancer. Development for PTB as a treatment for COVID-19 is being researched.

For further information please visit our website www.nascentbiotech.com

Media Contact

Organization: Nascent Biotech

Contact Person: Alex Jackson (Analyst)

Email: Send Email

State: Florida

City: Vero Beach

Country: United States

Website: http://www.nascentbiotech.com/

The post Nascent Biotech – Changing the Biotechnology Industry appeared first on King Newswire.

Information contained on this page is provided by an independent third-party content provider. Binary News Network and this site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

News

Lyfe, the first music artist to debut its own Metaverse

Miami, United States, June 21, 2022, ZEXPRWIRE, Miami-based entrepreneur Antonio Trincao, a.k.a. Lyfe, has unveiled the imminent release of his music album and the...

ButaneDAO Stands Apart for Launching a Groundbreaking DPOS Blockchain for Users

The company brings salutary solutions for users by launching a highly-effective DPOS blockchain. Cheyenne, Wyoming, United States, 24th May 2023 – By launching DPOS as...

Best Services Of AP News Press Release Is Now Available In Pakistan, Which Can Give Your Website Major SEO Benefits

AP news press release is the most practical and essential term, which proves helpful in creating awareness among the massive and targeted audience about...

Unizen and Meson API: A Two-Way Partnership Revolutionizing DeFi Access

Announcing the Unizen and Meson Partnership in DeFi DUBAI, UAE, Nov 23, 2023, ZEX PR WIRE, Unizen is excited to announce a strategic partnership with...

Centerra Ranch Montessori School Announces Exciting Innovations and Expansion to Enrich Early Education Experiences

Texas, US, 8th November 2023, ZEX PR WIRE, Known for its commitment to providing a nurturing environment that fosters curiosity, independence, and a love...

Francisco Faraco Believes People Are Better Off with Financial Advisors on FINRA BrokerCheck than Brokerage Software

While brokerage software can provide the most statistically likely option for investors, financial advisors use their years of industry experience to provide options that...

IDLE GOG: Endless War Is Coming to WEMIX PLAY

3D RPG card game based on Norse, Greek, and Chinese mythology and dealing with the war between gods and humans. Unique features include the Fusion...

Tiny Home Marketplace with Eco-friendly, Grid-free Units

United States, 3rd Jun 2022, King NewsWire, “Affordable tiny homes that reduce emissions and enable owners to live off the grid.” That’s the concept...

1,500+ Banksy NFTs Collection to be Launched by Mike Lin, Founder / CEO of T-Shirts Matter

California, US, 3rd February 2023, ZEXPRWIRE, 1,500+ Banksy NFTs Collection to be Launched by Mike Lin, Founder / CEO of T-Shirts Matter is Expected...